Is Actinium Pharmaceuticals Inc (ATNM) A Good Stock To Buy?

With a general bullishness amongst the heavyweights, some big names have jumped into Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) headfirst. Sabby Capital established the most valuable position in Actinium Pharmaceuticals Inc (NYSEMKT:ATNM). Sabby Capital had $0.1 million invested in the company at the end of the quarter. Balyasny Asset Management also made a $20,000 investment in the stock during the quarter. The only other fund with a new position in the stock is Ken Griffin’s Citadel Investment Group.

Let’s check out hedge fund activity in other stocks – not necessarily in the same industry as Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) but similarly valued. These stocks are Javelin Mortgage Investment Corp (NYSE:JMI), MeetMe Inc (NASDAQ:MEET), Hansen Medical, Inc. (NASDAQ:HNSN), and Perceptron, Inc. (NASDAQ:PRCP). All of these stocks’ market caps are similar to Actinium Pharmaceuticals Inc (NYSEMKT:ATNM)’s market cap.

As you can see, these stocks had an average of 5 hedge funds with bullish positions and the average amount invested in these stocks was $14 million. That figure was $1 million in Actinium Pharmaceuticals Inc (NYSEMKT:ATNM)’s case. Javelin Mortgage Investment Corp (NYSE:JMI) is the most popular stock in this table. On the other hand, MeetMe Inc (NASDAQ:MEET) is the least popular one with only 4 bullish hedge fund positions. Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) is not the least popular stock in this group, but hedge fund interest is still below average. This is a slightly negative signal and we’d rather spend our time researching stocks that hedge funds are piling on. In this regard, Javelin Mortgage Investment Corp (NYSE:JMI) might be a better candidate to consider a long position.